Philp D, Kleinman HK
Because methylcobalamin may be advantageous in treating chronically progressive MS as an immunosuppressive medication by enhancing oligodendrocyte maturation and clinical results [35,36,37], this study sought to collect information and review previous research on the function of Cbl in MS and to consider whether it can be applied in the future to treat this disease and its symptoms more effectively
He reviews your medical history, current medications, and what you are hoping to get out of the protocol
Albillos A, de Gottardi A, Rescigno M
This compound has garnered attention in longevity research due to its potential effects on cellular aging processes, particularly its influence on telomere maintenance and cellular repair mechanisms
MHRA Threat to clinics In communication with the MHRA, they also stated: However, we do have concerns about the level of clinical oversight present in IV vitamin therapy and injection services in general and the appropriacy of such services is currently under review. This review, if deciding on stopping treatment of B12 injections by clinics who do comply with the ridiculous rules of the MHRA, would not only negatively impact the companies and individuals who give B12 injections, but also to the people who rely on them to keep functioning both physically and mentally
